Preventing infections in patients undergoing hemodialysis

References

• Haley RW, Culver DH, White JW et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am. J. Epidemiol.121, 182–205 (1985).
   PubMed Web of Science ®Google Scholar
• U.S. Renal Data System, USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA (2009).
   Google Scholar
• Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Morb. Mortal. Wkly Rep.50(RR-5), 1–43 (2001).
   PubMedGoogle Scholar
• National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Clinical practice guidelines for vascular access, 2000. Am. J. Kidney Dis.37, S137–S181 (2001).
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Clinical practice guidelines for 2006 updates: hemodialysis adequacy, peritoneal dialysis adequacy, and vascular access. Am. J. Kidney Dis.48, S1–S322 (2006).
   Web of Science ®Google Scholar
• O’Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR Morb. Mortal. Wkly Rep.51(RR-10), 1–29 (2002).
   Google Scholar
• Boyce JM, Pittet D. Guidelines for hand hygiene in health-care settings. MMWR Morb. Mortal. Wkly Rep.51(RR-16), 1–45 (2002).
   Google Scholar
• George A, Tokars JI, Clutterbuck EJ, Bamford KB, Pusey C, Holmes AH. Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: prospective study. Br. Med. J.332, 1435–1439 (2006).
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Hepatitis: control measures for hepatitis B in dialysis centers. In: Viral Hepatitis Investigations and Control Series. CDC, Atlanta, GA, USA (1977).
   Google Scholar
• Miller ER, Alter MJ, Tokars JI. Protective effect of hepatitis B vaccine in chronic hemodialysis patients. Am. J. Kidney Dis.33, 356–360 (1999).
   PubMed Web of Science ®Google Scholar
• Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2002. Semin. Dial.18, 52–61 (2005).
   PubMed Web of Science ®Google Scholar
• Bond TC, Patel PR, Krisher J et al. Association of standing-order policies with vaccination rates in dialysis clinics: a US-based cross-sectional study. Am. J. Kidney Dis.54, 86–94 (2009).
   PubMedGoogle Scholar
• Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann. Intern. Med.144, 705–714 (2006).
   PubMed Web of Science ®Google Scholar
• Thompson ND, Novak RT, Datta D et al. Hepatitis C virus transmission in hemodialysis units: importance of infection control practices and aseptic technique. Infect. Control Hosp. Epidemiol.30, 900–903 (2009).
   PubMedGoogle Scholar
• Girou E, Chevaliez S, Challine D et al. Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit. Clin. Infect. Dis.47, 627–633 (2008).
   PubMedGoogle Scholar
• Fiore AE, Shay DK, Broder K et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices, 2009. MMWR Morb. Mortal. Wkly Rep.58(RR-8), 1–52 (2009).
   PubMedGoogle Scholar
• Gilbertson DT, Unruh M, McBean AM, Kausz AT, Snyder JJ, Collins AJ. Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int.63, 738–743 (2003).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Recommended adult immunization schedule – United States, 2009. MMWR Morb. Mortal. Wkly Rep.57 (2009).
   Google Scholar
• Pearson ML, Bridges CB, Harper SA. Influenza vaccination of health-care personnel: recommendations of the Healthcare Infection Control Practices Advisory Committee on Immunization Practices. MMWR Morb. Mortal. Wkly Rep.55(RR-2), 252 (2006).
   Google Scholar
• Saxon H, Virtanen M. Randomized, placebo-controlled double blind study on the efficacy of influenza immunization on absenteeism of health care workers. Pediatr. Inf. Dis. J.18, 779–783 (1999).
   PubMedGoogle Scholar
• Salgado CD, Giannetta ET, Hayden FG, Farr BM. Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect. Control Hosp. Epidemiol.25, 923–928 (2004).
   PubMed Web of Science ®Google Scholar
• Potter J, Stott DJ, Roberts MA et al. Influenza vaccination of health care workers in long-term care hospitals reduces the mortality of elderly patients. J. Infect. Dis.175, 1–6 (1997).
   PubMed Web of Science ®Google Scholar
• Lemaitre M, Meret T, Rothan-Tondeur M et al. Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial. J. Am. Geriatr. Soc.57, 1580–1586 (2009).
   PubMed Web of Science ®Google Scholar
• Tapiainen T, Bar G, Schaad UB, Heininger U. Influenza vaccination among healthcare workers in a university children’s hospital. Infect. Contr. Hosp. Epidemiol.26, 855–858 (2005).
   PubMed Web of Science ®Google Scholar
• Wodi AP, Samy S Ezeanolue E et al. Influenza vaccine: immunization rates, knowledge, and attributes of resident physicians in an urban teaching hospital. Infect. Control Hosp. Epidemiol.26, 867–873 (2005).
   PubMed Web of Science ®Google Scholar
• Goldstein AO, Kincade JE, Gamble G, Bearman RS. Policies and practices for improving influenza immunization rates among healthcare workers. Infect. Control Hosp. Epidemiol.25, 908–911 (2004).
   PubMed Web of Science ®Google Scholar
• Kallen AJ, Fiore AE. Overcoming challenges to influenza vaccination in patients with CKD. Am. J. Kidney Dis.54, 6–9 (2009).
   PubMedGoogle Scholar
• Engemann JJ, Friedman JY, Reed SD et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect. Control Hosp. Epidemiol.26, 534–539 (2005).
   PubMed Web of Science ®Google Scholar
• Klevens RM, Edwards JR, Andrus ML, Peterson KD, Dudeck TC, Horan TC. Dialysis surveillance report: National Healthcare Safety Network – data summary for 2006. Semin. Dial.21, 24–28 (2008).
   PubMedGoogle Scholar
• Dopirak M, Hill C, Oleksiw M et al. Surveillance of hemodialysis-associated primary bloodstream infections: the experience of ten hospital-based centers. Infect. Control Hosp. Epidemiol.23, 721–724 (2002).
   PubMedGoogle Scholar
• Lok CE. Fistula first initiative: advantages and pitfalls. Clin. J. Am. Soc. Nephrol.2, 1043–1053 (2007).
   PubMed Web of Science ®Google Scholar
• Hoffman KK, Weber DJ, Samsa GP, Rutala WA. Transparent polyurethane film as an intravenous catheter dressing: a meta-analysis of the infection risks. JAMA267, 2072–2076 (1992).
   PubMed Web of Science ®Google Scholar
• Gillies D, Carr D, Frost J, O’Riordan E, Gunning R, O’Brien I. Gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database Syst. Rev.3, CD003827 (2003).
   Google Scholar
• Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet338, 339–343 (1991).
   PubMed Web of Science ®Google Scholar
• Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann. Intern. Med.136, 792–801 (2002).
   PubMed Web of Science ®Google Scholar
• Mimoz O, Pieroni L, Lawrence C et al. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit. Care Med.24, 1818–1823 (1996).
   PubMed Web of Science ®Google Scholar
• Ash SR. The evolution and function of central venous catheters for dialysis. Semin. Dial.14, 416–424 (2001).
   PubMedGoogle Scholar
• Romero-Gómez MP, Quiles-Melero MI, Peña Garcia P et al. Outbreak of Burkholderia cepecia bacteremia caused by contaminated chlorhexidine in a hemodialysis unit. Infect. Control Hosp. Epidemiol.29, 377–378 (2008).
   PubMed Web of Science ®Google Scholar
• Kaitwatcharachai C, Silpapojakul K, Jitsurong S, Kalnauwakul S. An outbreak of Burkholderia cepecia bacteremia in hemodialysis patients: an epidemiologic and molecular study. Am. J. Kidney Dis.36, 199–204 (2000).
   PubMedGoogle Scholar
• Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheter infections by topical povidone iodine. Kidney Int.40, 934–938 (1991).
   PubMed Web of Science ®Google Scholar
• Sesso R, Barbosa D, Leme IL et al.Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J. Am. Soc. Nephrol.9, 1085–1092 (1998).
   PubMed Web of Science ®Google Scholar
• Johnson DW, van Eps C, Mudge DW et al. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J. Am. Soc. Nephrol.16, 1456–1462 (2005).
   PubMed Web of Science ®Google Scholar
• Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J. Hemodialysis infection prevention with polysporin ointment. J. Am. Soc. Nephrol.13, 169–179 (2003).
   Google Scholar
• James MT, Conley J, Tonelli M, Manns BJ, Macrae J, Hemmelgarn BR. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann. Intern. Med.148, 596–605 (2008).
   PubMed Web of Science ®Google Scholar
• Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized controlled trials. Clin. Infect. Dis.47, 83–93 (2008).
   PubMed Web of Science ®Google Scholar
• Jaffer Y, Shelby NM, Taal MW, Fluck RJ, McIntyre CW. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am. J. Kidney Dis.51, 233–241 (2008).
   PubMed Web of Science ®Google Scholar
• Labriola L, Crott R, Jadoul M. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol. Dial. Transplant23, 1666–1672 (2007).
   PubMedGoogle Scholar
• Abbas SA, Haloob IA, Taylor SL et al. Effect of antimicrobial locks for tunneled hemodialysis catheters on bloodstream infection and bacterial resistance: a quality improvement report. Am. J. Kidney Dis.53, 492–502 (2009).
   PubMedGoogle Scholar
• Dankert J, Uitentuis J, Houwen B, Tegzess AM, van der Hem GK. Hepatitis B surface antigen in environmental samples from hemodialysis units. J. Infect. Dis.134, 123–127 (1976).
   PubMedGoogle Scholar
• Favero MS, Maynard JE, Petersen NJ et al. Letter: Hepatitis-B antigen on environmental surfaces. Lancet2, 1455 (1973).
   PubMed Web of Science ®Google Scholar
• Bond WW, Petersen NJ, Favero MS. Viral hepatitis B: aspects of environmental control. Health Lab. Sci.14, 235–252 (1977).
   PubMedGoogle Scholar
• Froio N, Nicastri E, Comandini UV et al. Contamination by hepatitis B and C viruses in the dialysis setting. Am. J. Kidney Dis.42, 546–550 (2003).
   PubMedGoogle Scholar
• Arduino MJ. Dialysis-associated complications and their control. In: Bennett and Brachman’s Hospital Infections. Jarvis WR (Ed.). Lippincott Williams & Wilkins, PA, USA, 339–379 (2007).
   Google Scholar
• Snydman DR, Bryan JA, London WT et al. Transmission of hepatitis B associated with hemodialysis: role of malfunction (blood leaks) in dialysis machines. J. Infect. Dis.134, 562–570 (1976).
   PubMed Web of Science ®Google Scholar
• Tokars JI, Arduino MJ, Alter MJ. Infection control in hemodialysis units. Infect. Dis. Clin. North Am.15, 797–812 (2001).
   PubMedGoogle Scholar
• Weber DJ, Barbee SL, Sobsey MD, Rutala WA. The effect of blood on the antiviral activity of sodium hypochlorite, a phenolic, and a quaternary ammonium compound. Infect. Control Hosp. Epidemiol.20, 821–827 (1999).
   PubMedGoogle Scholar
• Thompson ND, Perz JF, Moorman AC, Holmberg SD. Non-hospital health care-associated hepatitis B and C virus transmission, United States, 1998–2008. Ann. Intern. Med.150, 33–39 (2009).
   PubMed Web of Science ®Google Scholar
• Grohskopf LA, Roth VR, Feiken DR et al.Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. N. Engl. J. Med.344, 1491–1497 (2001).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Infection control requirements for dialysis facilities and clarification regarding guidance on parenteral medication vials. MMWR Morb. Mortal. Wkly Rep.57, 875–876 (2008).
   PubMedGoogle Scholar
• Klevens RM, Morrison MA, Nadle J et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA298, 1763–1771 (2007).
   PubMed Web of Science ®Google Scholar
• Kutty PK, Benoit SR, Woods CW et al. Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005. Infect. Control Hosp. Epidemiol.29, 197–202 (2008).
   PubMed Web of Science ®Google Scholar
• Jones RN. Resistance patterns among nosocomial pathogens: trends over the past few years. Chest119(2 Suppl.), 397S–404S (2001).
   PubMed Web of Science ®Google Scholar
• Hidron AI, Edwards JR, Patel J et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect. Control Hosp. Epidemiol.29, 996–1011 (2008).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients, United States, 2005. MMWR Morb. Mortal. Wkly Rep.56, 197–199 (2007).
   PubMedGoogle Scholar
• Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC. Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin. Infect. Dis.46, 668–674 (2008).
   PubMed Web of Science ®Google Scholar
• Finks J, Wells E, Dyke TL et al. Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007. Emerg. Infect. Dis.15, 943–945 (2009).
   PubMed Web of Science ®Google Scholar
• Hadley AC, Karchmer TB, Russell GB, McBride DG, Freedman BI. The prevalence of resistant bacterial colonization in chronic hemodialysis patients. Am. J. Nephrol.27, 352–359 (2007).
   PubMedGoogle Scholar
• Gorwitz RJ, Kruszon-Moran D, McAllister SK et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004. J. Infect. Dis.197, 1226–1234 (2008).
   PubMed Web of Science ®Google Scholar
• Pop-Vicas A, Strom J, Stanley K, D’Agata EMC. Multidrug-resistant Gram-negative bacteria among patients who require chronic hemodialysis. J. Am. Soc. Nephrol.3, 752–758 (2008).
   Google Scholar
• Yu VL, Goetz A, Wagener M et al.Staphylococcus aureus nasal carriage and infections in patients on hemodialysis. N. Eng. J. Med.315, 91–96 (1986).
   PubMed Web of Science ®Google Scholar
• Engemann JJ, Friedman JY, Reed SD et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect. Control Hosp. Epidemiol.26, 534–539 (2005).
   PubMed Web of Science ®Google Scholar
• Nissenson AR, Dylan ML, Griffiths RI et al. Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis. Am. J. Kidney Dis.46, 301–308 (2005).
   PubMedGoogle Scholar
• Kallen AJ, Wilson CT, Larson RJ. Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis. Infect. Control Hosp. Epidemiol.26, 916–922 (2005).
   PubMed Web of Science ®Google Scholar
• Trautmann M, Stecher J, Hemmer W, Luz K, Pankin HT. Intranasal mupirocin prophylaxis in elective surgery. A review of published studies. Chemotherapy54, 9–16 (2008).
   PubMed Web of Science ®Google Scholar
• Kluytmans JA, Manders MJ, van Bommel E, Verbrugh H. Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients. Infect. Control Hosp. Epidemiol.17, 793–797 (1996).
   PubMed Web of Science ®Google Scholar
• Boelaert JR, DeSmedt RA, DeBaere YA et al. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol. Dial. Transplant.4, 278–281 (1989).
   PubMed Web of Science ®Google Scholar
• Boelaert JR, Van Landuyt HW, Godard CA et al. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Nephrol. Dial. Transplant.8, 235–239 (1993).
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, D’Agata EMC. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin. Infect. Dis.37, 1629–1638 (2003).
   PubMed Web of Science ®Google Scholar
• Perl TM, Cullen JJ, Wenzel RP et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N. Eng. J. Med.346, 1871–1877 (2002).
   PubMed Web of Science ®Google Scholar
• Jones JC, Rogers TJ, Brookmeyer P et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin. Infect. Dis.45, 541–547 (2007).
   PubMed Web of Science ®Google Scholar
• Edmond MB, Bearman GML. Mandatory public reporting in the USA: an example to follow? J. Hosp. Infect.65, 182–188 (2007).
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Reduction of central line-associated bloodstream infections among patients in intensive care units, Pennsylvannia, April 2001–March 2005. MMWR Morb. Mortal. Wkly Rep.54, 1013–1016 (2005).
   PubMedGoogle Scholar
• Pronovost P, Needham D, Berenholtz S et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N. Eng. J. Med.355, 2725–2732 (2006).
   PubMed Web of Science ®Google Scholar
• CDC. Transmission of hepatitis B and C viruses in outpatient settings, New York, Oklahoma, and Nebraska, 2000–2002. MMWR Morb. Mortal. Wkly Rep.52, 901–906 (2003).
   PubMedGoogle Scholar